Molecular basis of vascular anomalies

Trends in Cardiovascular Medicine

Volumn 8, Issue 7, 1998, Pages 281-292

  Vikkula, Miikka ^a   Boon, Laurence M ^a,b   Mulliken, John B ^c   Olsen, Bjorn R ^c  

^a DE DUVE INSTITUTE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTERIOVENOUS MALFORMATION; ATAXIA TELANGIECTASIA; BRAIN ARTERIOVENOUS MALFORMATION; DISEASE CLASSIFICATION; GENE MUTATION; HEMANGIOMA; HISTOLOGY; HUMAN; LYMPHANGIOMA; NONHUMAN; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; VASCULAR DISEASE; VASCULAR TUMOR; VON HIPPEL LINDAU DISEASE;

EID: 0032191924     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00024-3     Document Type: Article

References (99)

1. Achen M.G., Jeltsch M., Kukk E.et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA. 95:1998;548-553.
2. Aelvoet G.E., Jorens P.G., Roelen L.M. Genetic aspects of the Klippel-Trenaunay syndrome. Br J Dermatol. 126:1992;603-607.
3. Barsky S.H., Rosen S., Geer D.E., Noe J.M. The nature and evolution of port wine stains. a computer-assisted study J Invest Dermatol. 74:1980;154-157.
4. Bean W. Vascular Spiders and Related Lesions of the Skin. 1958;Thomas, Springfield, IL.
5. Bonyadi M., Rusholme S.A.B., Cousins F.M.et al. Mapping of a major genetic modifier of embryonic lethality in tgf beta 1 knockout mice. Nat Genet. 15:1997;207-211.
6. Boon L.M., Mulliken J.B., Vikkula M.et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 3:1994;1583-1587.
7. Boon L.M., Burrows P.E., Paltiel H.J.et al. Hepatic vascular anomalies in infancy. a twenty-seven-year experience J Pediatr. 129:1996;346-354. a.
8. Boon L.M., Enjolras O., Mulliken J.B. Congenital hemangioma. evidence of accelerated involution J Pediatr. 128:1996;329-335. b.
9. Bronshtein M., Bar Hava I., Blumenfeld Z. Early second-trimester sonographic appearance of occipital haemangioma simulating encephalocele. Prenat Diagn. 12:1992;695-698.
10. Brooks P.C., Montgomery A.M., Rosenfeld M.et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1994;1157-1164.
11. Bugge T.H., Xiao Q., Kombrinck K.W.et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA. 93:1996;6258-6263.
12. Burrows P.E., Fellows K.E. Techniques for management of pediatric vascular anomalies. Cope C. Current Techniques in Interventional Radiology. 1995;11-27 Current Medicine, Philadelphia.
13. Carmeliet P., Ferreira V., Breier G.et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439. a.
14. Carmeliet P., Mackman N., Moons L.et al. Role of tissue factor in embryonic blood vessel development. Nature. 383:1996;73-75. b.
15. Ceballos Quintal J.M., Pinto Escalante D., Castillo Zapata I. A new case of Klippel-Trenaunay-Weber (KTW) syndrome. evidence of autosomal dominant inheritance Am J Med Genet. 63:1996;426-427.
16. Cheung D.S.M., Warman M.L., Mulliken J.B. Hemangioma in twins. Ann Plast Surg. 38:1997;269-274.
17. Cohen M.M. Jr. Proteus syndrome. clinical evidence for somatic mosaicism and selective review Am J Med Genet. 47:1993;645-652.
18. Collod-Béroud G., Béroud C., Adès L.et al. Marfan Database (second edition). software and database for the analysis of mutations in the human FBN1 gene Nucleic Acids Res. 25:1997;147-150.
19. Davis S., Aldrich T.H., Jones P.F.et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
20. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121:1995;1845-1854.
21. Dubovsky J., Zabramski J.M., Kurth J.et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet. 4:1995;453-458.
22. Dumont D.J., Gradwohl G., Fong G.H.et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1994;1897-1909.
23. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo. a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development Dev Dyn. 203:1995;80-92.
24. Dupin N., Enjolras O., Wassef M.et al. Lack of evidence of any association between HHV-8 and hemangioma of the infancy. Ann Dermatol Venereol. 125:1998;98-99.
25. Enjolras O., Riché M.C., Merland J.J. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. 76:1985;48-51.
26. Enjolras O., Wassef M., Mazoyer E.et al. Infants with Kasabach-Merritt syndrome do not have true hemangiomas. J Pediatr. 130:1997;631-640.
27. Ezekowitz R.A., Mulliken J.B., Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 326:1992;1456-1463.
28. Finley J.L., Clark R.A., Colvin R.B., Blackman R., Noe J., Rosen S. Immunofluorescent staining with antibodies to factor VIII, fibronectin, and collagenous basement membrane protein in normal human skin and port wine stains. Arch Dermatol. 118:1982;971-975.
29. Folkman J, Mulliken JB, Ezekowitz AB: 1997. Antiangiogenic therapy of hemangiomas with interferon-alpha. In Stuart-Harris R, Penny RD, eds. Clinical Applications of the Interferons. London: Chapman and Hall Medical, pp 255-265.
30. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
31. Garden A.S., Benzie R.J., Miskin M., Gardner H.A. Fetal cystic hygroma colli. antenatal diagnosis, significance, and management Am J Obstet Gynecol. 154:1986;221-225.
32. George E.L., Georges Labouesse E.N., Patel King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1993;1079-1091.
33. Goodship J., Redfearn A., Milligan D., Gardner Medwin D., Burn J. Transmission of Proteus syndrome from father to son? J Med Genet. 28:1991;781-785.
34. Greenberg F., Carpenter R.J., Ledbetter D.H. Cystic hygroma and hydrops fetalis in a fetus with trisomy 13. Clin Genet. 24:1983;389-391.
35. Greenblatt R.M. Kaposi's sarcoma and human herpes virus-8. Infect Dis Clin North Am. 12:1998;63-82.
36. Greer P., Haigh J., Mbamalu G., Khoo W., Bernstein A., Pawson T. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol. 14:1994;6755-6763.
37. Gunel M., Awad I.A., Finberg K.et al. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery. 38:1996;1265-1271.
38. Hirschi K.K., Rohovsky S.A., D'Amore P.A. PDGF, TGF-β and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 141:1998;1-10.
39. Hoak J.C., Warner E.D., Cheng H.F., Fry G.L., Hankenson R.R. Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome). an animal model J Lab Clin Med. 77:1971;941-950.
40. Isik F.F., Rand R.P., Gruss J.S., Benjamin D., Alpers C.E. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res. 61:1996;71-76.
41. Isner J.M., Walsh K., Symes J.et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther. 7:1996;959-988.
42. Jacobs A.H., Walton R.G. The incidence of birthmarks in the neonate. Pediatrics. 58:1976;218-222.
43. Jeltsch M., Kaipainen A., Joukov V.et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425.
44. Johnson D.W., Berg J.N., Baldwin M.A.et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 13:1996;189-195.
45. Kaipainen A., Korhonen J., Mustonen T.et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 92:1995;3566-3570.
46. Kirby M.L., Waldo K.L. Neural crest and cardiovascular patterning. Circ Res. 77:1995;211-215.
47. Klippel M., Trenaunay P. Naevus variqueux ostéohypertrophique. Arch Gen Med III: 641:1900.
48. Knapik E.W., Goodman A., Atkinson O.S.et al. A reference cross DNA panel for zebrafish (Danio rerio) anchored with simple sequence length polymorphisms. Development. 123:1996;451-460.
49. Koblizek T.I., Weiss C., Yancopoulos G.D., Deutsch U., Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 8:1998;529-532.
50. Kohout M.P., Hansen M., Pribaz J.J., Mulliken J.B. Arteriovenous malformations of the head and neck. natural history and management Plastic Reconstr Surg. in press:1998.
51. Kontusaari S., Tromp G., Kuivaniemi H., Romanic A.M., Prockop D.J. A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms. J Clin Invest. 86:1990;1465-1473.
52. Kräling B.M., Razon M.J., Boon L.M.et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol. 148:1996;1181-1191.
53. Krüger G., Pelz L., Wiedemann H.R. Transmission of Proteus syndrome from mother to son? [letter]. Am J Med Genet. 45:1993;117-118.
54. Kukk E., Lymboussaki A., Taira S.et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 122:1996;3829-3837.
55. Kuo C.T., Veselits M.L., Barton K.P., Lu M.M., Clendenin C., Leiden J.M. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11:1997;2996-3006.
56. Lannutti B.J., Gately S.T., Quevedo M.E., Soff G.A., Paller A.S. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res. 57:1997;5277-5280.
57. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1994;1875-1887.
58. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in Pdgf B deficient mice. Science. 277:1997;242-245.
59. Lindenauer S.M. The Klippel-Trenaunay Syndrome. Ann Surg. 162:1965;303-314.
60. Maffucci A. Di un caso di encondroma ed angioma multiplo contribuzione alla ge-nesi embrionale del tumor. Mov Med Chir. 3:1881;399.
61. Maher E.R., Kaelin W.G. Jr. von Hippel-Lindau disease. Medicine. 76:1997;381-391.
62. Maisonpierre P.C., Suri C., Jones P.F.et al. Angiopoietin 2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
63. McAllister K.A., Grogg K.M., Johnson D.W.et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 8:1994;345-351. a.
64. McAllister K.A., Lennon F., Bowles Biesecker B.et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia. possible correlation with clinical phenotype J Med Genet. 31:1994;927-932. b.
65. McKusick VA, ed.: 1998. Online Mendelian Inheritance in Man. http://www3.ncbi.nlm . nih.gov/omim/.
66. Merlob P., Reisner S.H. Familial nevus flammeus of the forehead and Unna's nevus. Clin Genet. 27:1985;165-166.
67. Mitsuyasu R.T. Clinical aspects of AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 5:1993;835-844.
68. Mulliken J.B., Glowacki J. Classification of pediatric vascular lesions [letter]. Plast Reconstr Surg. 70:1982;120-121.
69. Mulliken J.B., Young A. Vascular Birthmarks. Hemangiomas and Malformations:1988;WB Saunders, Philadelphia.
70. Nakamura H. Electron microscopic study of the prenatal development of the thoracic aorta in the rat. Am J Anat. 181:1988;406-418.
71. O'Reilly M.S., Boehm T., Shing Y.et al. Endostatin. an endogenous inhibitor of angiogenesis and tumor growth Cell. 88:1997;277-285.
72. Ogita S., Tsuto T., Nakamura K., Deguchi E., Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 29:1994;784-785.
73. Oshima M., Oshima H., Taketo M.M. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 179:1996;297-302.
74. Piantanida M., Buscarini E., Dellavecchia C.et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet. 33:1996;441-443.
75. Razon M.J., Kräling B.M., Mulliken J.B., Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. in press:1998.
76. Risau W., Sariola H., Zerwes H.G.et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development. 102:1988;471-478.
77. Rudolph R. Familial multiple glomangiomas. Ann Plast Surg. 30:1993;183-185.
78. Sarkar M., Mulliken J.B., Kozakewich H.P.W., Robertson R.L., Burrows P.E. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common hemangioma. Plast Reconstr Surg. 100:1997;1377-1386.
79. Sato T.N., Tozawa Y., Deutsch U.et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:1995;70-74.
80. Shalaby F., Rossant J., Yamaguchi T.P.et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
81. Shovlin C.L., Hughes J.M., Tuddenham E.G.et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 6:1994;205-209.
82. Sibinga N.E., Foster L.C., Hsieh C.M.et al. Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ Res. 80:1997;532-541.
83. Singh R.K., Gutman M., Bucana C.D., Sanchez R., Llansa N., Fidler I.J. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA. 92:1995;4562-4566.
84. Smoller B.R., Rosen S. Port-wine stains. a disease of altered neural modulation of blood vessels? Arch Dermatol. 122:1986;177-179.
85. Stainier D.Y., Fouquet B., Chen J.N.et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 123:1996;285-292.
86. Superti-Furga A., Gugler E., Gitzelmann R., Steinmann B. Ehlers-Danlos syndrome type IV. a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen J Biol Chem. 263:1988;6226-6232.
87. Suri C., Jones P.F., Patan S., Bartunkova S.et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
88. Takahashi K., Mulliken J.B., Kozakewich H.P., Rogers R.A., Folkman J., Ezekowitz R.A. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 93:1994;2357-2364.
89. Takeshita S., Zheng L.P., Brogi E.et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 93:1994;662-670.
90. Toomey J.R., Kratzer K.E., Lasky N.M., Stanton J.J., Broze G.J. Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood. 88:1996;1583-1587.
91. Toomey J.R., Kratzer K.E., Lasky N.M., Broze G.J. Jr. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA. 94:1997;6922-6926.
92. Vikkula M., Boon L.M., Carraway K.L.R.et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 87:1996;1181-1190.
93. Vincent P., Plauchu H., Hazan J., Faure S., Weissenbach J., Godet J. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet. 4:1995;945-949.
94. Whelan A.J., Watson M.S., Porter F.D., Steiner R.D. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. Am J Med Genet. 59:1995;492-494.
95. Whimster I.W. The pathology of lymphangioma circumscriptum. Br J Dermatol. 94:1976;473-486.
96. Williams R.L., Risau W., Zerwes H.G., Drexler H., Aguzzi A., Wagner E.F. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 57:1989;1053-1063.
97. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178.
98. Woods C.G. DNA repair disorders. Arch Dis Child. 78:1998;178-184.
99. Zumkeller R. A propos de la frequence et de l'hérédité du naevus vasculosus nuchae (Unna). Incidence and heredity of nevus vasculosus nuchae (Unna). J Genet Hum. 6:1957;1-12.